CICC Insights: Factor Product Growth Promising in Blood Products Industry; Focus on New Product R&D Progress
2025-08-20 / Read about 0 minute
Author:小编   

According to CICC, the blood product industry is anticipated to sustain steady growth in the latter half of the year. Amidst the stabilization of product prices, the upsurge in plasma collection volumes by enterprises, and the introduction of novel products, performance is poised for an uptick. Investors are advised to keep a close watch on industry leaders that are continually expanding their plasma station resources through a combination of organic growth and expansion strategies, as their blood product businesses are expected to achieve sustained growth.